Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events-Reference-Cited by-同舟云学术

Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events

Published:2009-10-31 Issue:1 Volume:14 Page:43-50
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Sugiura Sachiyo,Inaguma Daijo,Kitagawa Akimitsu,Murata Minako,Kamimura Yutaka,Sendo Sho,Hamaguchi Kyoko,Nagaya Hiroshi,Tatematsu Miho,Kurata Kei,Yuzawa Yukio,Matsuo Seiichi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10157-009-0233-z.pdf

Reference28 articles.

1. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:8–28.

2. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 1999;277:157–75.

3. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79:362–71.

4. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–11.

5. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Int Med. 2008;168:1340–9.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM);Nefrología (English Edition);2023-06

2. Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica: 2021 (SEN-MM);Nefrología;2022-12

3. Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study;Frontiers in Medicine;2022-01-21

4. Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis;Renal Failure;2021-01-01

5. Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method;Clinical and Experimental Nephrology;2018-05-10